Advertisement
amit mudgill
Amit Mudgill

Amit Mudgill

tvtn

amit.mudgill@aajtak.com

A market journalist with over 14 years of experience in print and digital journalism, I am 24/7 on the go. Greeting ‘Good Night’ to Dow Jones and ‘Good Morning’ to SGX Nifty come naturally to me. Ask me about data and you will hear stories. I am not so active on social media, but have eyes and ears on the ground. If not tracking markets, I love gazing stars and planets,  astrophotography, reading a lot about what’s happening in India’s neighbourhood and playing video games.

SHOW MORE...

AMC stocks gained because investors were probably expecting that the SEBI will come heavily and may reduce the kind of fee that AMCs charge by a large amount.

ICICI Prudential AMC vs HDFC AMC vs Nippon: Vinit Bolinjkar shares pecking order

by Amit Mudgill |Dec 19, 2025

Bolinjkar said he is positive on the asset management space as a whole and that ICICI Prudential AMC is his top pick in the pecking order.

Sharma's views came as the year 2025 is ending with nearly 2,600 listed stocks delivering negative returns in excess of 10 per cent.

Max pleasure, max pain: Shankar Sharma’s inescapable truth about stock market

by Amit Mudgill |Dec 19, 2025

Sharma's views came as the year 2025 is ending with nearly 2,600 listed stocks delivering negative returns in excess of 10 per cent. 

UBS in a note on December 17 valued the stock at three-year forward EV-to-Ebitda of 40 times, in-line with multiples of Eternal and Nykaa

Meesho shares tumble 7% after 43% surge in 4-day rally; what's ahead?

by Amit Mudgill |Dec 19, 2025

With Friday's fall, Meesho shares have fallen below UBS' 12-month target price of Rs 220. Another brokerage Choice Broking had suggested a target of Rs 200 on the stock. 

Jubilant Pharmova Ltd rose 1.6 per cent to Rs 1,070.25. Suven Life Sciences added 2.35 per cent while Sai Life Sciences added up 1 per cent.

Laurus Labs, Divis: Why pharma stocks are rising today

by Amit Mudgill |Dec 19, 2025

Pharma stock Laurus Labs advanced 2.42 per cent to Rs 1,039.70.  Divis Laboratories Ltd gained 1.87 per cent to Rs 6500.10. Gland Pharma added 0.34 per cent to Rs 1,671.55. 

MOFSL said it remains positive on the IT sector from a medium- to long-term perspective, anticipating a recovery in macro and AI adoption to accelerate enterprise tech spending.

TCS, Infosys, HCL Tech, Wipro, TechM: Key takeaways from Accenture Q1 results

by Amit Mudgill |Dec 19, 2025

MOFSL said AI services demand could begin to improve from mid-2026 as hardware-led AI capex intensity moderates. The March-April 2026 budget reset period may serve as an initial indicators, it said.

BEML's defence revenue is expected to see multi-fold growth, with the brokerage projecting 70–80 per cent year-on-year growth in FY26, following a doubling of defence sales in FY25.

BEML: Railway, defence PSU stock gets 60% upside target! 

by Amit Mudgill |Dec 19, 2025

BEML share price target: Elara trimmed its target price to Rs 2,700, valuing the stock at 37 times September FY27 estimated earnings, citing a slight delay in the execution of the Vande Bharat sleeper...

This will enable Vi to bolster its capex and support business growth. The fresh fundraise reinforces investor confidence.

Vodafone Idea shares in focus as subsidiary raises Rs 3,300 crore via NCDs

by Amit Mudgill |Dec 19, 2025

VI share price: Proceeds from the issuance will be utilised by VITIL to repay its payment obligations to Vodafone Idea. 

Equirus described ICICI Prudential AMC as India’s largest equity-focused asset manager, with a 13.4 per cent share of equity AUM.

ICICI Prudential AMC IPO: Equirus sets share price target at Rs 2,900 ahead of market listing

by Amit Mudgill |Dec 19, 2025

The brokerage said ICICI Prudential AMC traded at around 30 times FY27 estimated earnings and 26 times FY28 estimates, at a 10–15 per cent discount to its closest peer.

Jefferies also flagged record foreign portfolio investor outflows, with foreign investors selling a net $17.8 billion of Indian equities so far in calendar 2025.

Stock market: Jefferies on India’s weakest relative run in 30 years, surprise weak rupee

by Amit Mudgill |Dec 19, 2025

Jefferies’ head of India research, Mahesh Nandurkar, argued that there was no immediate cause for panic on the currency front, citing supportive external balances and reserve adequacy.

 Two promoters Sumita Mishra and Ira Mishra owned 1.27 per cent stake in the firm.

RRP Semiconductor: 2 employees, 74,000% return & perplexed investors 

by Amit Mudgill |Dec 18, 2025

RRP Semiconductor had 528 retail investors at the end of September quarter and 14 individual investors with over Rs 2 lakh worth stocks.